Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 28 citing articles:

Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial
Carlos Fierro, Daniel C. Brune, Marian Shaw, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e668-e678
Open Access | Times Cited: 18
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 6
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
Hsuan-Yuan Wang, Leike Li, Cody S. Nelson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 22
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies.
Eric P. Schultz, Lars Ponsness, Jean-Marc Lanchy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies
Eric P. Schultz, Lars Ponsness, Jean-Marc Lanchy, et al.
Journal of Virology (2025)
Open Access
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition
Wei‐Hung Chen, JungHyun Kim, Wei Bu, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 2135-2148.e6
Open Access | Times Cited: 17
Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease
Marcos Nuévalos, Estéfani García‐Ríos, Francisco J. Mancebo, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 5, pp. 480-497
Closed Access | Times Cited: 10
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
Andrea Parsons, Sabrina I. Ophir, J. Andrew Duty, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 15
Continuous multi-membrane chromatography of large viral particles
Tiago R. Matos, David Hoying, Adam Kristopeit, et al.
Journal of Chromatography A (2023) Vol. 1705, pp. 464194-464194
Closed Access | Times Cited: 7
Novel technologies are turning a dream into reality: conditionally replicating viruses as vaccines
Yan‐Dong Tang, Changqing Yu, Xuehui Cai
Trends in Microbiology (2023) Vol. 32, Iss. 3, pp. 292-301
Closed Access | Times Cited: 7
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine
Xiaohua Ye, David Shih, Zhiqiang Ku, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Immunization of Mice with Virus-Like Vesicles of Kaposi Sarcoma-Associated Herpesvirus Reveals a Role for Antibodies Targeting ORF4 in Activating Complement-Mediated Neutralization
Alex K. Lam, Romin Roshan, Wendell Miley, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 5
The pentameric complex is not required for vertical transmission of cytomegalovirus in seronegative pregnant rhesus macaques
Hsuan-Yuan Wang, Husam Taher, Craig N. Kreklywich, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
A novel rotavirus reverse genetics platform supports flexible insertion of exogenous genes and enables rapid development of a high-throughput neutralization assay
Jiajie Wei, Scott Radcliffe, Meiqing Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Investigation into the use of gamma irradiated Cytodex-1 microcarriers to produce a human cytomegalovirus (HCMV) vaccine candidate in epithelial cells
Daniel Spatafore, Donald Warakomski, Carl Hofmann, et al.
Journal of Biotechnology (2023) Vol. 365, pp. 62-71
Closed Access | Times Cited: 2
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection
Sarah Valencia, Eric Rochat, Melissa J. Harnois, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 2
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in mice
Leike Li, Yankai Wen, Daniel Wrapp, et al.
Antibody Therapeutics (2022) Vol. 6, Iss. 1, pp. 1-12
Open Access | Times Cited: 3
Development and characterization of HCMV recombinant subunit vaccines based on T-cell epitopes
Jun Li, Xu Li, Fengjun Liu, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126454-126454
Closed Access
Navigating paediatric virology through the COVID‑19 era (Review)
Ioannis Mammas, Simon B. Drysdale, Charalampos Charalampous, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 3
Open Access | Times Cited: 1
Ligands and receptors in human cytomegalovirus entry: Current therapies and new directions
Min Zhang, Xiaochen Wang, Jianshe Li, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103833-103833
Closed Access | Times Cited: 1
Antibody Titers Against Human Cytomegalovirus gM/gN and gB Among Pregnant Women and Their Infants
Maria M. Talavera‐Barber, Kaitlyn Flint, Brianna Graber, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 2
Vaccination with a disabled infectious single cycle cytomegalovirus vaccine elicits a distinct glycoprotein B-specific monoclonal antibody repertoire compared to that of naturally-infected individuals
Sarah Valencia, Eric Rochat, Melissa J. Harnois, et al.
Research Square (Research Square) (2023)
Open Access
Cytomegalovirus Vaccines
Mark R. Schleiss
Elsevier eBooks (2023), pp. 258-274.e9
Closed Access
Page 1 - Next Page

Scroll to top